The goal of the expert network funded by the Leibniz Association is to develop conceptually new, innovative and highly specific approaches to the prevention and treatment of diseases of the central nervous system.

One of the biggest challenges within the treatment of such diseases (eg. stress-associated mental disorders) is the fact that substances have to cross the blood-brain barrier (BBB) to reach their target site in the brain. Stress-related depressive disorders are one of the main causes of chronic illnesses worldwide, and there is an urgent need for a beakthrough in treatment as well as prevention.

Scientists from the Leibniz Institute for Resilience Research, the University Medical Center Mainz, the Johannes Gutenberg University Mainz, the Max Planck Institute for Polymer Research, the Institute of Molecular Biology and TRON bundle their expertise in the field of nanomedicine and mRNA technology with translational stress and resilience research to provide solutions to this problem.

The Leibniz Association funds this ScienceCampus with 1,200,000 € over a period of four years. This is a fantastic opportunity for the life science and neuroscience community in Mainz to connect research strengths.

We are glad to be part of the pioneering network and looking forward to the collaboration.

Read more here.